Hengrui Medicine (01276): The SHR-7012 injection, intended for the treatment of cutaneous lupus erythematosus, has been approved for clinical trials.

Wuyi Horizon (06651) has established a joint venture with United Imaging to launch AperData, an embodied intelligence data platform.

CanSino Biologics (06185): The tetanus vaccine has received NDA approval from the National Medical Products Administration.

Beijing Energy International (00686): A subsidiary plans to invest 236 million yuan in the comprehensive energy socialized investment cooperation project at Beijing University of Technology.

In terms of operational performance, BABA-W (09988) reported a 75.56% year-on-year decline in first-quarter net profit attributable to shareholders, while AI-related product revenue continued to see triple-digit growth for the twelfth consecutive quarter.

Ping An Insurance (02318) released its interim results, with net profit attributable to shareholders reaching 92.585 billion yuan, up 36.06% year-on-year.

NetEase (09999) achieved net revenue of approximately 60.7 billion yuan in the first half of the year, up 7.0% year-on-year, with long-term game operations and new product pipelines supporting sustained development.

China Telecom (00728) posted interim results with profit attributable to shareholders of 19.588 billion yuan, down 14.9% year-on-year.

CITIC Securities (06030) reported interim results with net profit attributable to shareholders of 23.343 billion yuan, up 69.6% year-on-year.

Pop Mart (09992) released interim results with profit attributable to shareholders of 5.038 billion yuan, up 10.1% year-on-year, as plush product revenue sustained strong growth momentum.

Henderson Land Development (00012) posted interim results with profit attributable to shareholders of HK$4.09 billion, up 40.65% year-on-year.

China Tourism Group Duty Free (01880) announced interim results with profit attributable to equity shareholders of approximately 3.134 billion yuan, up 19.52% year-on-year.

J&T Express-W (01519) released interim results with adjusted net profit of US$351 million, up 124.3% year-on-year.

BOC Aviation (02588) posted interim results with after-tax net profit of US$357 million, up 4% year-on-year.

Li Ning (02331) announced interim results with net profit attributable to equity holders of 1.816 billion yuan, up 4.53% year-on-year.

3SBio (01530) released interim results with profit attributable to shareholders of 1.147 billion yuan, down 15.58% year-on-year.

Simeere Pharmaceutical (02096) announced interim results with adjusted net profit of approximately 964 million yuan, up 48.7% year-on-year.

Cloud Music (09899) reported interim results with revenue of approximately 3.959 billion yuan, up 3.4% year-on-year.

Dongyue Group (00189) released interim results with profit attributable to shareholders of 1.027 billion yuan for the period, up 31.84% year-on-year.

Blue Moon Group (06993) released interim results with revenue of HK$2.883 billion, reflecting steadily improving operational efficiency.

Hua Medicine-B (02552) posted interim results with revenue up 74% year-on-year to 378.9 million yuan, as its self-commercialization strategy proves effective.

Zhou Hei Ya (01458) saw first-half revenue grow 19.5% year-on-year to 1.461 billion yuan, with channel business experiencing rapid growth as the company expands into compound seasoning and overseas markets.